Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-12-18 Sale | 2024-12-20 9:30 pm | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 822,397 | $3.7388 | $3,074,764 | 2,294,583 (Direct) | View |
2024-12-18 Sale | 2024-12-20 9:30 pm | Checkpoint Therapeutics Inc. | CKPT | GRAY WILLIAM GARRETT Chief Financial Officer | 268,432 | $4.01 | $1,076,412 | 1,032,754 (Direct) | View |
2024-06-26 Sale | 2024-06-28 8:01 pm | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 24,610 | $2.05 | $50,450 | 1,939,280 (Direct) | View |
2024-06-26 Sale | 2024-06-28 8:00 pm | Checkpoint Therapeutics Inc. | CKPT | GRAY WILLIAM GARRETT Chief Financial Officer | 13,038 | $2.06 | $26,858 | 672,186 (Direct) | View |
2024-02-28 Sale | 2024-03-01 8:31 pm | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 5,894 | $2.06 | $12,142 | 341,780 (Direct) | View |
2024-02-28 Sale | 2024-03-01 8:30 pm | Checkpoint Therapeutics Inc. | CKPT | GRAY WILLIAM GARRETT Chief Financial Officer | 2,035 | $2.07 | $4,212 | 145,224 (Direct) | View |
2024-02-01 Sale | 2024-02-02 8:15 pm | Checkpoint Therapeutics Inc. | CKPT | GRAY WILLIAM GARRETT Chief Financial Officer | 4,115 | $1.95 | $8,024 | 147,259 (Direct) | View |
2024-02-01 Sale | 2024-02-02 8:10 pm | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 11,900 | $2.01 | $23,919 | 356,730 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-12-20 Gift | 2024-12-20 9:30 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 900,000 | $0 | 2,294,583 (Direct) | View |
2024-12-13 Option Award | 2024-12-17 9:33 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | WEISS MICHAEL S Director | 12,638 | $0 | 124,812 (Indirect) | View |
2024-12-13 Option Award | 2024-12-17 9:33 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | SALZMAN BARRY M Director | 17,638 | $0 | 134,812 (Direct) | View |
2024-12-13 Option Award | 2024-12-17 9:32 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | ROSENWALD LINDSAY A MD Director | 12,638 | $0 | 144,812 (Direct) | View |
2024-12-13 Option Award | 2024-12-17 9:32 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 2,077,700 | $0 | 4,016,980 (Direct) | View |
2024-12-13 Option Award | 2024-12-17 9:31 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | GRAY WILLIAM GARRETT Chief Financial Officer | 629,000 | $0 | 1,301,186 (Direct) | View |
2024-12-13 Option Award | 2024-12-17 9:30 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Bechon Christian Director | 14,994 | $0 | 129,523 (Direct) | View |
2024-12-13 Option Award | 2024-12-17 9:30 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Herskowitz Neil Director | 17,638 | $0 | 134,812 (Direct) | View |
2024-09-27 Option Award | 2024-10-01 4:15 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Fortress Biotech Inc. 10% Owner | 146,341 | $0 | 3,735,534 (Direct) | View |
2024-06-26 Gift | 2024-06-28 8:01 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 37,890 | $0 | 1,939,280 (Direct) | View |
2024-05-24 Option Award | 2024-05-24 9:01 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | GRAY WILLIAM GARRETT Chief Financial Officer | 540,000 | $0 | 685,224 (Direct) | View |
2024-05-24 Option Award | 2024-05-24 9:00 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 1,660,000 | $0 | 2,001,780 (Direct) | View |
Ownership | 2024-05-24 4:05 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Fortress Biotech Inc. 10% Owner | 0 | $0 | 4,289,193 (Direct) | View |
2024-05-14 Option Award | 2024-05-16 7:35 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | WEISS MICHAEL S Director | 82,051 | $0 | 112,174 (Indirect) | View |
2024-05-14 Option Award | 2024-05-16 7:34 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Amit Sharma Director | 32,051 | $0 | 82,051 (Direct) | View |
2024-05-14 Option Award | 2024-05-16 7:33 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | SALZMAN BARRY M Director | 82,051 | $0 | 117,174 (Direct) | View |
2024-05-14 Option Award | 2024-05-16 7:32 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | ROSENWALD LINDSAY A MD Director | 82,051 | $0 | 132,174 (Direct) | View |
2024-05-14 Option Award | 2024-05-16 7:31 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Herskowitz Neil Director | 82,051 | $0 | 117,174 (Direct) | View |
2024-05-14 Option Award | 2024-05-16 7:30 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Bechon Christian Director | 82,051 | $0 | 114,529 (Direct) | View |
2024-03-20 Option Award | 2024-03-22 6:23 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Fortress Biotech Inc. 10% Owner | 193,905 | $0 | 2,096,278 (Direct) | View |
Ownership | 2024-03-19 8:00 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Amit Sharma Director | 0 | $0 | 50,000 (Direct) | View |
2024-02-28 Gift | 2024-03-01 8:31 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 9,056 | $0 | 341,780 (Direct) | View |
2024-02-01 Gift | 2024-02-02 8:10 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 12,950 | $0 | 356,730 (Direct) | View |
2023-02-24 Ownership | 2024-02-02 8:05 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 54,510 | $0 | 381,580 (Direct) | View |
2023-12-29 Option Award | 2024-01-03 4:28 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Fortress Biotech Inc. 10% Owner | 158,134 | $0 | 1,902,373 (Direct) | View |
2023-09-25 Option Award | 2023-09-26 4:16 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Fortress Biotech Inc. 10% Owner | 80,906 | $0 | 1,744,239 (Direct) | View |
2023-06-30 Option Award | 2023-07-03 1:15 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Fortress Biotech Inc. 10% Owner | 81,406 | $0 | 1,663,333 (Direct) | View |
2023-06-13 Option Award | 2023-06-15 8:01 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | WEISS MICHAEL S Director | 17,483 | $0 | 30,123 (Indirect) | View |
2023-06-13 Option Award | 2023-06-15 8:01 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | SALZMAN BARRY M Director | 17,483 | $0 | 35,123 (Direct) | View |
2023-06-13 Option Award | 2023-06-15 8:00 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | ROSENWALD LINDSAY A MD Director | 17,483 | $0 | 50,123 (Direct) | View |
2023-06-13 Option Award | 2023-06-15 8:00 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Herskowitz Neil Director | 17,483 | $0 | 35,123 (Direct) | View |
2023-06-13 Option Award | 2023-06-15 8:00 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Boilen Scott Director | 17,483 | $0 | 37,345 (Direct) | View |
2023-06-13 Option Award | 2023-06-15 8:00 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Bechon Christian Director | 17,483 | $0 | 32,478 (Direct) | View |
2023-03-31 Option Award | 2023-04-04 8:30 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 250,000 | $0 | 394,090 (Direct) | View |
2023-03-31 Option Award | 2023-04-04 8:30 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | GRAY WILLIAM GARRETT Chief Financial Officer | 100,000 | $0 | 151,374 (Direct) | View |
2023-03-31 Option Award | 2023-04-04 4:06 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Fortress Biotech Inc. 10% Owner | 78,214 | $0 | 1,581,927 (Direct) | View |